BioCorRx Inc.
BICX
$0.36
$0.025.88%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.59% | -29.65% | |||
| Depreciation & Amortization | 90.77% | 94.03% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.61% | -32.23% | |||
| Operating Income | 16.61% | 32.23% | |||
| Income Before Tax | 30.61% | 18.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.61% | 18.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -83.49% | 146.09% | |||
| Net Income | 27.75% | 21.70% | |||
| EBIT | 16.61% | 32.23% | |||
| EBITDA | 17.86% | 32.75% | |||
| EPS Basic | 39.19% | 32.84% | |||
| Normalized Basic EPS | 45.51% | 30.92% | |||
| EPS Diluted | 39.19% | 32.84% | |||
| Normalized Diluted EPS | 45.51% | 30.92% | |||
| Average Basic Shares Outstanding | 18.68% | 16.60% | |||
| Average Diluted Shares Outstanding | 18.68% | 16.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||